{"id":"W2949232069","doi":"10.1136/annrheumdis-2019-eular.3403","title":"THU0167 SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Discontinuation; Adverse effect; Placebo; Adalimumab; Internal medicine; Methotrexate; Phases of clinical research; Clinical trial; Pharmacology; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004489226,0.0007292659,0.001767984,0.0006110106,0.0003678791,0.00157747,0.0005591864,0.000661975,0.004984809],"category_scores_gemma":[0.002721764,0.0003447962,0.003372608,0.001004957,0.0004666221,0.0006429909,0.0004632366,0.002079431,0.001261657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001030862,"about_ca_system_score_gemma":0.002764843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001179239,"about_ca_topic_score_gemma":0.004079523,"domain_scores_codex":[0.9985066,0.0007262477,0.0000876121,0.0001521455,0.0003396139,0.0001877934],"domain_scores_gemma":[0.9981832,0.0004467151,0.000573791,0.0001654251,0.0003446486,0.000286201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.4561645,0.01002797,0.0725885,0.003391663,0.01862459,0.0003110485,0.0002659197,0.009387234,0.02097372,0.0009714515,0.0343318,0.3729616],"study_design_scores_gemma":[0.3187259,0.2722325,0.2907544,0.001069151,0.03127312,0.002284016,0.000472342,0.01064987,0.01270761,0.001580354,0.057961,0.0002897047],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9529531,0.01014008,0.001892617,0.001244266,0.0001496824,0.00208426,0.02297148,0.0002433284,0.008321174],"genre_scores_gemma":[0.9474673,0.006602768,0.002595667,0.002085984,0.0002368673,0.001798814,0.03491339,0.000125035,0.004174202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004984809,"threshold_uncertainty_score":0.0237416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04611880106264763,"score_gpt":0.3990381520886491,"score_spread":0.3529193510260014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}